Clinical Trials Recruitment

With advancements in medical technology and the introduction of new drugs in recent years, the survival rate and life expectancy of cancer patients have significantly increased. Cancer used to be a dreaded disease, but has now gradually transformed into a chronic illness. However, as treatments improve, cancer cells also begin to develop resistance to treatment, leading to a long battle with researchers.

To bring hope to cancer patients, it is crucial for patients and the public to actively participate in clinical trial recruitment. Clinical trials help healthcare professionals address the challenges they face in treating patients and accelerate the development of new cancer drugs that can be used for different types and stages of cancer, enabling healthcare professionals to use new drugs to defeat cancer.

In Hong Kong, clinical trials are typically conducted in different hospitals or medical centres. Prospective participants must meet the recruitment criteria of the clinical trial and undergo a rigorous screening process to participate.

We are currently recruiting qualified patients to participate in the following clinical studies. If you are interested and would like to know your eligibility to participate, please contact our staff for more information:

Clinical Trials Recruitment

• 1.Recruitment for patients with Advanced or Metastatic Colorectal Cancer
• 2.Clinical Trial for advanced metastatic colon cancer

To know more about clinical trials, contact us via:

If you want to learn about other clinical trials that are currently recruiting in Hong Kong, you can visit the websites of university Clinical Trial Centres below:

• University of Hong Kong Clinical Trials Centre (https://public.hkuctc.com/tc)
• Chinese University of Hong Kong Phase 1 Clinical Trials Centre (https://www.p1ctc.med.cuhk.edu.hk/zh-hk/%E9%A6%96%E9%A0%81.aspx)

The development of new drugs is a lengthy process. In the early stages of development, researchers need to conduct a series of complex studies and tests in the laboratory, including testing on animals, to understand the drug’s effects on a living organism. Before a new drug is released on the market, researchers need to evaluate its effectiveness in humans through clinical trials. Researchers use pharmacokinetic modelling to calculate the lowest effective dose for human use and ensure the safety of clinical trials. Data shows that new cancer drugs developed through clinical trials have significantly improved patient outcomes.

Due to the different methods used to verify pharmacology, effectiveness, and safety, clinical trials are usually divided into several phases to find answers to different questions. Generally speaking, clinical trials can be divided into four phases.

Clinical Trials Recruitment allows patients to receive cutting-edge treatments that may not be available through standard care and clinical protocols. Clinical trials provide access to new drugs and treatments that can potentially improve patient outcomes and quality of life. Additionally, Clinical Trials Recruitment helps to advance medical knowledge and improve treatments for future patients.

• Clinical Trials Recruitment must meet specific criteria, so not all patients may be eligible to participate.
• Clinical trials generally use double-blind randomised controlled trials, meaning that participants or investigators cannot determine the treatment groups (in effect, “blind” to the treatment group allocation). Therefore there is a chance that a given patient may not necessarily be able to try the new drug or treatment should they be allocated to the control group (e.g., placebo or standard treatment group)
• Because the medical team needs clinic to closely observe the patient’s condition, patients need to spend more time and resources to regularly return to the research centre or hospital for follow-up.
• As the new drug is still under research, some of its risks and side effects may not be well understood.